Quarterly report · Q1
4480.TEDINET S100TESW
Period2024-01-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.9bn | 2024-01-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥20.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.4bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥246m | 2024-01-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥380m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥723m | 2024-01-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.8bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥503m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥725m | 2024-01-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥550m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥466m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥358m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥497m | 2024-01-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥381m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥30.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥25.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥21.8bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥15.6bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.6bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2023-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥14.4 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.53 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.15 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥14.31 | 2024-01-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.55 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥10.97 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 58.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥1.0bn |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥1.9bn |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥1.9bn |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥175m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥123m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥123m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥71m |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥3.9bn |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥3.9bn |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥0 |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-03-31 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-03-31 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥573m |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q1r_E33586-000Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥32m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥88m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥88m |
| jpcrp040300-q1r_E33586-000New Business Development Servicesreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥44m |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥2.9bn |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥2.9bn |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| jpcrp040300-q1r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥965m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-03-31 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-03-31 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-03-31 | ¥954m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 354
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |